Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease

NCT06984484 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DEVICE: Afluxin®
DRUG: Placebo

Sponsor

Devintec Sagl